{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:22:25Z","timestamp":1792549345596,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020956","name":"Merck Healthcare KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004950","name":"Aston University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017194","name":"UCLA Asia Pacific Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.metabol.2026.156589","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:57:30Z","timestamp":1773129450000},"page":"156589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Metformin: Antidiabetic actions from cells to tissues"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6998-6811","authenticated-orcid":false,"given":"Clifford J.","family":"Bailey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gwilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin M.G.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2026.156589_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.15663","article-title":"Metformin: therapeutic profile in the treatment of type 2 diabetes","volume":"26","author":"Bailey","year":"2024","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.metabol.2026.156589_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155160","article-title":"Metformin and the heart: update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure","volume":"130","author":"Schernthaner","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156589_bb0015","first-page":"1655","article-title":"International PCOS Network, recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome, human reproduction","volume":"38","author":"Teede","year":"2023"},{"key":"10.1016\/j.metabol.2026.156589_bb0020","author":"National Institute for Health and Care Excellence"},{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2026.156589_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/dom.15756","article-title":"Metformin beyond type 2 diabetes: emerging and potential new indications","volume":"26","author":"Petrie","year":"2024","journal-title":"Diabetes Obes Metab."},{"issue":"9","key":"10.1016\/j.metabol.2026.156589_bb0030","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.metabol.2026.156589_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"La Moia","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2026.156589_bb0040","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"10.1016\/j.metabol.2026.156589_bb0045","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.metabol.2026.156589_bb0050","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.metabol.2026.156589_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031264","article-title":"Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport","volume":"23","author":"Herman","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"2","key":"10.1016\/j.metabol.2026.156589_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","article-title":"Metformin action: concentrations matter","volume":"21","author":"He","year":"2015","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156589_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00498259409043220","article-title":"Accumulation of metformin by tissues of the normal and diabetic mouse","volume":"24","author":"Wilcock","year":"1994","journal-title":"Xenobiotica"},{"issue":"8","key":"10.1016\/j.metabol.2026.156589_bb0070","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","article-title":"Metformin and the intestine","volume":"51","author":"Bailey","year":"2008","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.metabol.2026.156589_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.metabol.2026.156589_bb0080","series-title":"Metformin 500 mg film coated tablets","year":"2025"},{"key":"10.1016\/j.metabol.2026.156589_bb0085","series-title":"Metformin hydrochloride 500 mg Prolonged-release Tablets","year":"2024"},{"issue":"2","key":"10.1016\/j.metabol.2026.156589_bb0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.1981.tb01206.x","article-title":"Metformin kinetics in healthy subjects and in patients with diabetes mellitus","volume":"12","author":"Tucker","year":"1981","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156589_bb0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199630050-00003","article-title":"Clinical pharmacokinetics of metformin","volume":"30","author":"Scheen","year":"1996","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.metabol.2026.156589_bb0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40262-015-0323-x","article-title":"Therapeutic concentrations of metformin: a systematic review","volume":"55","author":"Kajbaf","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.metabol.2026.156589_bb0105","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.xphs.2017.04.078","article-title":"Transporters involved in metformin pharmacokinetics and treatment response","volume":"106","author":"Liang","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.metabol.2026.156589_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1183879","article-title":"Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis","volume":"11","author":"Peng","year":"2023","journal-title":"Front Public Health"},{"issue":"24","key":"10.1016\/j.metabol.2026.156589_bb0115","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.2014.15298","article-title":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review","volume":"312","author":"Inzucchi","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2026.156589_bb0120","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2147\/TCRM.S372430","article-title":"Quality and characteristics of 4241 case reports of lactic acidosis in metformin users reported to a large pharmacovigilance database","volume":"18","author":"Brand","year":"2022","journal-title":"Therap Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.metabol.2026.156589_bb0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Diethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.metabol.2026.156589_bb0130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic eff8cts through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2026.156589_bb0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20140620","article-title":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria","volume":"462","author":"Bridges","year":"2014","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2026.156589_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1126\/science.ade3332","article-title":"Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides","volume":"379","author":"Bridges","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.metabol.2026.156589_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00294","article-title":"Role of mitochondria in the mechanism(s) of action of metformin","volume":"10","author":"Vial","year":"2019","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.metabol.2026.156589_bb0150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.2042-7158.1991.tb03507.x","article-title":"Subcellular distribution of metformin in rat liver","volume":"43","author":"Wilcock","year":"1991","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.taap.2008.08.013","article-title":"Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro","volume":"288","author":"Dykens","year":"2008","journal-title":"Toxicol Appl Pharmacol."},{"issue":"6","key":"10.1016\/j.metabol.2026.156589_bb0160","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","article-title":"Metformin improves mitochondrial respiratory activity through activation of AMPK","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.metabol.2026.156589_bb0165","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1074\/jbc.RA118.006670","article-title":"Low metformin causes a more oxidized mitochondrial NADH\/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism","volume":"294","author":"Alshawi","year":"2019","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.metabol.2026.156589_bb0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1210\/en.2013-1750","article-title":"AMPK in the small intestine in normal and pathophysiological conditions","volume":"155","author":"Harmel","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2026.156589_bb0175","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nm.3787","article-title":"Metformin activates a duodenal Ampk\u2013dependent pathway to lower hepatic glucose production in rats","volume":"21","author":"Duca","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2026.156589_bb0180","article-title":"Metabolic regulation by the intestinal metformin-AMPK axis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.metabol.2026.156589_bb0185","first-page":"212","article-title":"Effect of metformin on glucose metabolism in mouse soleus muscle","volume":"12","author":"Bailey","year":"1986","journal-title":"Diabetes Metab"},{"issue":"7506","key":"10.1016\/j.metabol.2026.156589_bb0190","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156589_bb0195","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122287119","article-title":"Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis","volume":"119","author":"LaMoia","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"30","key":"10.1016\/j.metabol.2026.156589_bb0200","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","article-title":"Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK)","volume":"289","author":"Cao","year":"2014","journal-title":"J Biol Chem."},{"issue":"11","key":"10.1016\/j.metabol.2026.156589_bb0205","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.tips.2020.09.001","article-title":"Metformin and systemic metabolism","volume":"41","author":"He","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2026.156589_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106114","article-title":"Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications","volume":"177","author":"Feng","year":"2022","journal-title":"Pharmacol Res"},{"issue":"9","key":"10.1016\/j.metabol.2026.156589_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093240","article-title":"The metformin mechanism on gluconeogenesis and AMPK activation: the metabolite perspective","volume":"21","author":"Agius","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2026.156589_bb0220","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1111\/jcmm.14834","article-title":"Metformin upregulates mitophagy in patients with T2DM: A randomized placebo-controlled study","volume":"24","author":"Bhansali","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2026.156589_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102342","article-title":"Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients","volume":"53","author":"de Mara\u00f1\u00f3n","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2026.156589_bb0230","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.metabol.2026.156589_bb0235","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.metabol.2026.156589_bb0240","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1074\/jbc.M114.604421","article-title":"Metformin activates AMP-activated protein kinase by promoting formation of the \u03b1\u03b2\u03b3 heterotrimeric complex","volume":"290","author":"Meng","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156589_bb0245","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2026.156589_bb0250","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmet.2016.09.003","article-title":"Metformin activates AMPK through the lysosomal pathway","volume":"24","author":"Zhang","year":"2016","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.metabol.2026.156589_bb0255","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-022-00661-7","article-title":"PEN2: metformin\u2019s new partner at lysosome","volume":"32","author":"Sakamoto","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.metabol.2026.156589_bb0260","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156589_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.81","article-title":"Regulation and function of AMPK in physiology and diseases","volume":"48","author":"Jeon","year":"2016","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.metabol.2026.156589_bb0270","doi-asserted-by":"crossref","unstructured":"McGee SL, van Denderen BJW, Howlett KF, Mollica J, Schertzer JD, Kemp BE, et al. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 2008; 57: 860\u2013867. doi:https:\/\/doi.org\/10.2337\/db07-0843.","DOI":"10.2337\/db07-0843"},{"issue":"1","key":"10.1016\/j.metabol.2026.156589_bb0275","article-title":"Unraveling the AMPK-SIRT1-FOXO pathway: the in-depth analysis and breakthrough prospects of oxidative stress-induced diseases","volume":"14","author":"Guan","year":"2025","journal-title":"Antioxidants (Basel)"},{"issue":"10","key":"10.1016\/j.metabol.2026.156589_bb0280","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.celrep.2019.10.117","article-title":"Quantitative in vivo proteomics of metformin response in liver reveals AMPK-dependent and -independent signaling networks","volume":"29","author":"Stein","year":"2019","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.metabol.2026.156589_bb0285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF00250897","article-title":"Effect of metformin on hepatocyte insulin receptor binding in normal, streptozotocin diabetic and genetically obese diabetic (ob\/ob) mice","volume":"25","author":"Lord","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156589_bb0290","series-title":"Handbook of experimental pharmacology","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-3-662-09127-2_12","article-title":"Preclinical pharmacology of biguanides","volume":"119","author":"Wiernsperger","year":"1996"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2026.156589_bb0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003495-199958001-00009","article-title":"The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms","volume":"58","author":"Wiernsperger","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2026.156589_bb0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.bjp.0704878","article-title":"Metformin enhances insulin signalling in insulin-dependent and -independent pathways in insulin resistant muscle cells","volume":"137","author":"Kumar","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0305","doi-asserted-by":"crossref","first-page":"E427","DOI":"10.1210\/jc.2010-2060","article-title":"Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells","volume":"96","author":"Rice","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0310","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.bcp.2004.02.016","article-title":"Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase","volume":"67","author":"Holland","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.metabol.2026.156589_bb0315","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/jc.2002-021394","article-title":"Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2","volume":"88","author":"Gunton","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0320","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1096\/fj.201800529RR","article-title":"Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity","volume":"33","author":"Polianskyte-Prause","year":"2019","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.metabol.2026.156589_bb0325","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13349","article-title":"SHIPping out diabetes-metformin, an old friend among new SHIP2 inhibitors","volume":"228","author":"Lehtonen","year":"2020","journal-title":"Acta Physiol (Oxf)"},{"issue":"3","key":"10.1016\/j.metabol.2026.156589_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031264","article-title":"Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport","volume":"23","author":"Herman","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.metabol.2026.156589_bb0335","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","article-title":"Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2026.156589_bb0340","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/dom.12910","article-title":"Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes","volume":"19","author":"Al-Oanzi","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.metabol.2026.156589_bb0345","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/biom11060873","article-title":"Metformin targets Foxo1 to control glucose homeostasis","volume":"11","author":"Guo","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.metabol.2026.156589_bb0350","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1476-5381.1994.tb14807.x","article-title":"Insulin requirement for the antihyperglycaemic effect of metformin","volume":"111","author":"Bailey","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0355","first-page":"89","article-title":"Metformin: a review of its metabolic effects","volume":"6","author":"Cusi","year":"1998","journal-title":"Diabetes Review"},{"key":"10.1016\/j.metabol.2026.156589_bb0360","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1464-5491.2009.02847.x","article-title":"Role of glucotoxicity and lipotoxicity in the pathophysiology of type 2 diabetes mellitus and emerging treatment strategies","volume":"26","author":"Del Prato","year":"2009","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.metabol.2026.156589_bb0365","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41591-018-0159-7","article-title":"Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase","volume":"24","author":"Hunter","year":"2018","journal-title":"Nat Med"},{"issue":"7436","key":"10.1016\/j.metabol.2026.156589_bb0370","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156589_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10856","article-title":"AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B","volume":"7","author":"Johanns","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2026.156589_bb0380","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3389\/fendo.2018.00657","article-title":"Metformin is a direct SIRT1-activating compound: computational modeling and experimental validation","volume":"9","author":"Cuy\u00e0s","year":"2018","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1016\/j.metabol.2026.156589_bb0385","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.13262","article-title":"Epigenetic effects of metformin: from molecular mechanisms to clinical implications","volume":"20","author":"Bridgeman","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0390","doi-asserted-by":"crossref","first-page":"17313","DOI":"10.1039\/C5CC04321B","article-title":"The copper binding properties of metformin QCM-D, XPS and nanobead agglomeration","volume":"51","author":"Quan","year":"2015","journal-title":"Chem Commun"},{"key":"10.1016\/j.metabol.2026.156589_bb0395","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10863-006-9003-8","article-title":"The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin","volume":"38","author":"Batandier","year":"2006","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.metabol.2026.156589_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1330797","article-title":"Examining the clinical relevance of metformin as an antioxidant intervention","volume":"15","author":"Buczy\u0144ska","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0405","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.2147\/DMSO.S286430","article-title":"Effects of metformin on the gut microbiota in obesity and type 2 diabetes mellitus","volume":"13","author":"Zhang","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7","key":"10.1016\/j.metabol.2026.156589_bb0410","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc20-2257","article-title":"Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial","volume":"44","author":"Mueller","year":"2021","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.metabol.2026.156589_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073566","article-title":"The relationship between the gut microbiome and metformin as a key for treating type 2 diabetes mellitus","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2026.156589_bb0420","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.metabol.2026.156589_bb0425","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s42255-025-01336-4","article-title":"Combining a diet rich in fermentable carbohydrates with metformin improves glycaemic control and reshapes the gut microbiota in people with prediabetes","volume":"7","author":"Chu","year":"2025","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/ph18010055","article-title":"The gut microbiota-related antihyperglycemic effect of metformin","volume":"18","author":"Szymczak-Pajor","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.metabol.2026.156589_bb0435","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.metabol.2026.156589_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137379","article-title":"The role of short chain fatty acids in inflammation and body health","volume":"25","author":"Du","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2026.156589_bb0445","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.2042-7158.1991.tb06645.x","article-title":"Reconsideration of inhibitory effect of metformin on intestinal glucose absorption","volume":"43","author":"Wilcock","year":"1991","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0450","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1476-5381.1992.tb09093.x","article-title":"Effect of metformin on glucose metabolism in the splanchnic bed","volume":"105","author":"Bailey","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0455","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1476-5381.1994.tb13128.x","article-title":"Importance of the intestine as a site of metformin-stimulated glucose utilization","volume":"112","author":"Bailey","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0460","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads5466","article-title":"Metformin targets mitochondrial complex I to lower blood glucose levels","volume":"10","author":"Reczek","year":"2024","journal-title":"Sci Adv"},{"issue":"7795","key":"10.1016\/j.metabol.2026.156589_bb0465","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.metabol.2026.156589_bb0470","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.3390\/ijms23115929","article-title":"Metformin protects the intestinal barrier by activating goblet cell maturation and epithelial proliferation in radiation-induced enteropathy","volume":"23","author":"Jang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2026.156589_bb0475","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0006-2952(95)02243-0","article-title":"Effects of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats","volume":"51","author":"Lenzen","year":"1996","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.metabol.2026.156589_bb0480","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211933120","article-title":"Metformin acts in the gut and induces gut-liver crosstalk","volume":"120","author":"Tobar","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2026.156589_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1347047","article-title":"Understanding the action mechanisms of metformin in the gastrointestinal tract","volume":"15","author":"Cheng","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0490","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cmet.2017.09.019","article-title":"Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway","volume":"27","author":"Bauer","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106057","article-title":"Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes","volume":"26","author":"Zubiaga","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.metabol.2026.156589_bb0500","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1111\/dom.16570","article-title":"Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administration","volume":"27","author":"Borg","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101807","article-title":"Metformin increases the uptake of glucose into the gut from the circulation in high-fat diet-fed male mice, which is enhanced by a reduction in whole-body Slc2a2 expression","volume":"77","author":"Morrice","year":"2023","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156589_bb0510","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13340-021-00545-y","article-title":"Metformin action in the gut-insight provided by [18F]FDG PET imaging","volume":"13","author":"Tsuchida","year":"2021","journal-title":"Diabetol Int"},{"key":"10.1016\/j.metabol.2026.156589_bb0515","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-025-00755-4","article-title":"Metformin-regulated glucose flux from the circulation to the intestinal lumen","volume":"5","author":"Sakaguchi","year":"2025","journal-title":"Commun Med"},{"key":"10.1016\/j.metabol.2026.156589_bb0520","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s12276-025-01518-w","article-title":"Novel mechanism whereby metformin improves glucose homeostasis: TXNIP\u2013GLUT1 axis modulation enhances intestinal glucotonic effects","volume":"57","author":"Kang","year":"2025","journal-title":"Exp Mol Med"},{"issue":"8","key":"10.1016\/j.metabol.2026.156589_bb0525","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1096-9136(199808)15:8<651::AID-DIA628>3.0.CO;2-A","article-title":"Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus","volume":"15","author":"Scarpello","year":"1998","journal-title":"Diabetes Med"},{"key":"10.1016\/j.metabol.2026.156589_bb0530","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1463-1326.2002.00223.x","article-title":"Effects of metformin on bile salt transport by monolayers of human intestinal Caco-2 cells","volume":"4","author":"Carter","year":"2002","journal-title":"Diab Obes Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0535","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1463-1326.2003.00252.x","article-title":"Differential effects of metformin on bile salt absorption from jejunum and ileum","volume":"5","author":"Carter","year":"2003","journal-title":"Diab Obes Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2004.01328.x","article-title":"The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review","volume":"256","author":"Wulffele","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2026.156589_bb0545","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.peptides.2017.11.008","article-title":"Targeted intestinal delivery of incretin secretagogues-towards new diabetes and obesity therapies","volume":"100","author":"Gribble","year":"2018","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.metabol.2026.156589_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100778","article-title":"Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus","volume":"9","author":"Napolitano","year":"2014","journal-title":"PLoS ONE"},{"issue":"23","key":"10.1016\/j.metabol.2026.156589_bb0555","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93936","article-title":"Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes","volume":"3","author":"Bahne","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2026.156589_bb0560","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1464-5491.2005.01461.x","article-title":"Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes","volume":"22","author":"Lindsay","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2026.156589_bb0565","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2006.07.043","article-title":"Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1","volume":"547","author":"Green","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171168","article-title":"Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes","volume":"174","author":"Bailey","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.metabol.2026.156589_bb0575","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s42255-024-00999-9","article-title":"Lac-Phe mediates the effects of metformin on food intake and body weight","volume":"6","author":"Xiao","year":"2024","journal-title":"Nat Metab"},{"issue":"11","key":"10.1016\/j.metabol.2026.156589_bb0580","first-page":"4059","article-title":"Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus","volume":"81","author":"Cusi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.metabol.2026.156589_bb0585","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","article-title":"Mechanism by which metformin reduces glucose production in type 2 diabetes","volume":"49","author":"Hundal","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156589_bb0590","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","volume":"333","author":"Stumvoll","year":"1995","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.metabol.2026.156589_bb0595","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00125-019-4872-7","article-title":"Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes","volume":"62","author":"Gormsen","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.metabol.2026.156589_bb0600","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BCJ20220582","article-title":"AMPK inhibits liver gluconeogenesis: fact or fiction?","volume":"480","author":"Johanns","year":"2023","journal-title":"Biochem J"},{"issue":"22","key":"10.1016\/j.metabol.2026.156589_bb0605","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/0006-2952(88)90617-X","article-title":"Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin","volume":"37","author":"Wollen","year":"1988","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"10.1016\/j.metabol.2026.156589_bb0610","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41591-018-0125-4","article-title":"Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo","volume":"24","author":"Madiraju1","year":"2018","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.metabol.2026.156589_bb0615","doi-asserted-by":"crossref","first-page":"E1099","DOI":"10.1152\/ajpendo.00417.2013","article-title":"Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle","volume":"306","author":"Kristensen","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.metabol.2026.156589_bb0620","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-73-6-1294","article-title":"Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects","volume":"73","author":"DeFronzo","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0625","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2026.156589_bb0630","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0006-2952(98)00151-8","article-title":"Prevention of dexamethasone-induced insulin resistance by metformin","volume":"56","author":"Thomas","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.metabol.2026.156589_bb0635","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/bj3480083","article-title":"Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin","volume":"348","author":"Pryor","year":"2000","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.metabol.2026.156589_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032227","article-title":"Anti-obesity effects of metformin: a scoping review evaluating the feasibility of brown adipose tissue as a therapeutic target","volume":"24","author":"Ziqubu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.metabol.2026.156589_bb0645","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1172\/JCI63967","article-title":"Malonyl-CoA: the regulator of fatty acid synthesis and oxidation","volume":"122","author":"Foster","year":"2012","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.metabol.2026.156589_bb0650","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070810","article-title":"Metabolic action of metformin","volume":"15","author":"Szymczak-Pajor","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.metabol.2026.156589_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102171","article-title":"Metformin reduces macrophage HIF1\u03b1-dependent proinflammatory signaling to restore brown adipocyte function in vitro","volume":"48","author":"Pescador","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2026.156589_bb0660","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0922-4106(93)90011-W","article-title":"Metformin and brown adipose tissue thermogenetic activity in genetically obese Zucker rats","volume":"246","author":"Rouru","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.metabol.2026.156589_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171293","article-title":"Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats","volume":"12","author":"Tokubuchi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2026.156589_bb0670","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopha.2019.01.021","article-title":"Metformin enhances mitochondrial biogenesis and thermogenesis in brown adipocytes of mice","volume":"111","author":"Karise","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.metabol.2026.156589_bb0675","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/JOE-21-0194","article-title":"Metformin as an anti-inflammatory agent: a short review","volume":"251","author":"Krist\u00f3fi","year":"2021","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2026.156589_bb0680","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1330797","article-title":"Examining the clinical relevance of metformin as an antioxidant intervention","volume":"15","author":"Buczy\u0144ska","year":"2024","journal-title":"Front Pharmacol."},{"issue":"8","key":"10.1016\/j.metabol.2026.156589_bb0685","article-title":"Role of metformin in polycystic ovary syndrome (PCOS)-related infertility","volume":"15","author":"Attia","year":"2023","journal-title":"Cureus"},{"issue":"13","key":"10.1016\/j.metabol.2026.156589_bb0690","article-title":"Diabetes, metformin and the clinical course of covid-19: outcomes, mechanisms and suggestions on the therapeutic use of metformin","volume":"9","author":"Bailey","year":"2022","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156589_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/v16121938","article-title":"Metformin in antiviral therapy: evidence and perspectives","volume":"16","author":"Halabitska","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.metabol.2026.156589_bb0700","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of metformin in attenuating the hallmarks of aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156589_bb0705","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12967-023-04263-8","article-title":"Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing","volume":"21","author":"Hua","year":"2023","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.metabol.2026.156589_bb0710","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4103\/1673-5374.385286","article-title":"Promising use of metformin in treating neurological disorders: biomarker-guided therapies","volume":"19","author":"Loan","year":"2024","journal-title":"Neural Regen Res"},{"issue":"24","key":"10.1016\/j.metabol.2026.156589_bb0715","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.2014.15298","article-title":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review","volume":"312","author":"Inzucchi","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2026.156589_bb0720","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03300-y","article-title":"Metformin use and early lactate levels in critically ill patients according to chronic and acute renal impairment","volume":"24","author":"Posma","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.metabol.2026.156589_bb0725","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-134-9_Part_1-200105010-00008","article-title":"Maternally inherited diabetes and deafness: a multicenter study","volume":"134","author":"Guillausseau","year":"2001","journal-title":"Ann Intern Med."},{"issue":"4","key":"10.1016\/j.metabol.2026.156589_bb0730","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/js.2017-00434","article-title":"Endocrine disorders in primary mitochondrial disease","volume":"2","author":"Al-Gadi","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.metabol.2026.156589_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101850","article-title":"Interplay of mitochondria and diabetes: unveiling novel therapeutic strategies","volume":"75","author":"Xiao Liang","year":"2024","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.metabol.2026.156589_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2025.101678","article-title":"Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations","volume":"51","author":"Ng","year":"2025","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2026.156589_bb0745","article-title":"Heightened sensitivity to adverse effects of metformin in mtDNA mutant patient cells","volume":"366\u2013367","author":"Ryytty","year":"2025","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.metabol.2026.156589_bb0750","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s10072-024-07343-9","article-title":"A case of exacerbated encephalopathy with stroke-like episodes and lactic acidosis triggered by metformin in a patient with MELAS","volume":"45","author":"Shin","year":"2024","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.metabol.2026.156589_bb0755","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/L20-0292","article-title":"MELAS syndrome and MIDD unmasked by metforminose: a case report","volume":"174","author":"Kim","year":"2021","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.metabol.2026.156589_bb0760","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/15563650.2021.1966029","article-title":"Initiation of metformin in MELAS patient-a dangerous combination","volume":"60","author":"Trebach","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"issue":"Supplement 2","key":"10.1016\/j.metabol.2026.156589_bb0765","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.nmd.2016.06.334","article-title":"Metformin-induced deafness in mitochondrial disease","volume":"26","author":"Brady","year":"2016","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.metabol.2026.156589_bb0770","doi-asserted-by":"crossref","first-page":"863047","DOI":"10.3389\/fneur.2022.863047","article-title":"Case report: late-onset mitochondrial disease uncovered by metformin use in a patient with acute verbal auditory agnosia","volume":"13","author":"Lin","year":"2022","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.metabol.2026.156589_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.108111","article-title":"Neurological manifestations in m.3243A>G-related disease triggered by metformin","volume":"36","author":"Tong","year":"2022","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.metabol.2026.156589_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107080","article-title":"Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes","volume":"32","author":"Murakami","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"10.1016\/j.metabol.2026.156589_bb0785","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4239\/wjd.v14.i5.585","article-title":"Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes","volume":"14","author":"Sayedali","year":"2023","journal-title":"World J Diabetes"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526000995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526000995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:12:52Z","timestamp":1779163972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526000995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":157,"alternative-id":["S0026049526000995"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156589","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin: Antidiabetic actions from cells to tissues","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156589"}}